Page last updated: 2024-08-21

chenodeoxycholic acid and Libman-Sacks Disease

chenodeoxycholic acid has been researched along with Libman-Sacks Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, J; Chen, M; Lian, F; Liang, L; Wang, Y; Xu, H; Yang, X; Ye, Y; Zhan, Z	1

Other Studies

1 other study(ies) available for chenodeoxycholic acid and Libman-Sacks Disease

Article	Year
Activation of farnesoid X receptor attenuates liver injury in systemic lupus erythematosus. Rheumatology international, 2012, Volume: 32, Issue:6 Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Case-Control Studies; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Concanavalin A; Cytoprotection; Disease Models, Animal; Female; Humans; Inflammation Mediators; Interferon-gamma; Interleukin-6; Liver; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, Inbred MRL lpr; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha	2012

Article

Year

Activation of farnesoid X receptor attenuates liver injury in systemic lupus erythematosus.

Rheumatology international, 2012, Volume: 32, Issue:6

Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Case-Control Studies; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Concanavalin A; Cytoprotection; Disease Models, Animal; Female; Humans; Inflammation Mediators; Interferon-gamma; Interleukin-6; Liver; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, Inbred MRL lpr; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha

2012